Teva Pharmaceutical Industries LimitedTeva Pharmaceutical Industries LimitedTeva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited

No trades
No trades

Compare with Teva Pharmaceutical Industries Limited


Market capitalization
‪38.33 B‬USD
1.37USD
‪1.42 B‬USD
‪17.46 B‬USD
‪1.16 B‬
Beta (1Y)
1.10
Next report date
Report period
EPS estimate
Revenue estimate

Profile


CEO
Richard Francis
Headquarters
Tel Aviv
Founded
1901
IPO date
Jan 1, 1951
ISIN
US8816242098
CUSIP
881624209
FIGI
BBG000C0CD58
Identifiers
ISIN US8816242098
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
6.150% YTM
Maturity dateOct 1, 2046
Coupon4.10% (Fixed)
5.909% YTM
Maturity dateOct 1, 2026
Coupon3.15% (Fixed)
5.489% YTM
Maturity dateFeb 1, 2036
Coupon6.15% (Fixed)
5.340% YTM
Maturity dateDec 1, 2032
Coupon6.00% (Fixed)
5.133% YTM
Maturity dateDec 1, 2030
Coupon5.75% (Fixed)
5.280% YTM
Maturity dateMar 1, 2028
Coupon6.75% (Fixed)
4.017% YTM
Maturity dateJun 1, 2031
Coupon4.13% (Fixed)
3.558% YTM
Maturity dateOct 15, 2028
Coupon1.63% (Fixed)
3.462% YTM
Maturity dateMar 31, 2027
Coupon1.88% (Fixed)
YTM
Maturity dateMay 9, 2027
Coupon4.75% (Variable)
YTM
Maturity dateSep 15, 2031
Coupon7.88% (Variable)

See all TEVA bonds 

Weight0.15%
Market value‪285.00 M‬
Weight0.18%
Market value‪135.43 M‬
Weight9.54%
Market value‪83.59 M‬
Weight0.04%
Market value‪63.45 M‬
Weight0.04%
Market value‪63.45 M‬
Weight0.04%
Market value‪63.45 M‬
Weight0.35%
Market value‪59.01 M‬
Weight0.09%
Market value‪53.57 M‬
Weight3.02%
Market value‪50.15 M‬
Weight0.11%
Market value‪45.09 M‬

Explore more ETFs